HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial-Reference-Cited by-同舟云学术

HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial

Published:2020-05-20 Issue:5 Volume:35 Page:2306-2315
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Yang Tong,Ng Derry Minyao,Du Nannan,He Ning,Dai Xiaoyu,Chen Ping,Wu Feng,Chen Bo,Fan Xiaoxiang,Yan Kun,Zhou Xinfeng,Dong Mingjun,Zheng Zhi,Gu Lihu^ORCID

Funder

the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00464-020-07644-y.pdf

Reference37 articles.

1. Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135

2. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722

3. Nordlinger B, Sorbye H, Glimelius B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208–1215